Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Killer cell lectin-like receptor K1, commonly known as NKG2D, is a type II transmembrane protein belonging to the NKG2 family of C-type lectin-like receptors, encoded by the KLRK1 gene on chromosome 12p13.2. It functions as an activating and costimulatory receptor primarily expressed on natural killer (NK) cells, CD8+ T cells, and γδ T cells, where it recognizes stress-inducible ligands such as MICA, MICB, and ULBPs on the surface of virus-infected, transformed, or stressed cells. Upon ligand binding, NKG2D associates with the adaptor protein DAP10/DAP12, triggering signaling cascades that promote calcium influx, cytokine production (e.g., TNF-alpha), and perforin-mediated cytotoxicity, thereby enabling immunosurveillance against tumors and pathogens. In adaptive immunity, it amplifies T-cell receptor signaling in CD8+ T cells. Dysregulation of NKG2D expression or polymorphisms in KLRK1 are linked to altered NK cell activity, increased cancer risk, autoimmune disorders like celiac disease, and susceptibility to infections such as cowpox. Although no approved drugs directly target NKG2D, its role in recognizing stressed cells positions it as a promising therapeutic target for enhancing anti-tumor immunity or modulating immune responses in cancer and infectious diseases.
null
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Killer cell lectin-like receptor K1 (NKG2D) (NKG2D).